Vitamin D Levels in the United States: Temporal Trends (2011–2018) and Contemporary Associations with Sociodemographic Characteristics (2017–2018)
Subramanian A, Burrowes H, Rumph J, Wilkerson J, Jackson C, Jukic A. Vitamin D Levels in the United States: Temporal Trends (2011–2018) and Contemporary Associations with Sociodemographic Characteristics (2017–2018). Nutrients 2024, 16: 3414. PMID: 39408379, PMCID: PMC11478591, DOI: 10.3390/nu16193414.Peer-Reviewed Original ResearchConceptsNational Health and Nutrition Examination SurveyNon-Hispanic black femalesVitamin D levelsNational Health and Nutrition Examination Surveys survey cyclesHealth and Nutrition Examination SurveyNon-Hispanic blacksAssociated with larger decrementsNutrition Examination SurveyMedian 25(OH)DD levelsPredictors of 25(OH)D levelsMultivariate linear regressionExamination SurveyPrevalence of 25(OH)DSurvey cyclesWeighted medianLevels of 25(OH)DSociodemographic characteristicsVitamin D supplementationFemales of reproductive ageHigher BMILow-incomeIncreased BMIMexican AmericansVitamin D dataIrregular Cycles, Ovulatory Disorders, and Cardiometabolic Conditions in a US-Based Digital Cohort
Wang Z, Jukic A, Baird D, Wilcox A, Li H, Curry C, Fischer-Colbrie T, Onnela J, Williams M, Hauser R, Coull B, Mahalingaiah S. Irregular Cycles, Ovulatory Disorders, and Cardiometabolic Conditions in a US-Based Digital Cohort. JAMA Network Open 2024, 7: e249657. PMID: 38700861, PMCID: PMC11069087, DOI: 10.1001/jamanetworkopen.2024.9657.Peer-Reviewed Original ResearchConceptsPolycystic ovary syndromeCardiometabolic conditionsPrevalence odds ratiosAssociated with type 2 diabetesTransient ischemic attackType 2 diabetesAssociation of polycystic ovary syndromeIrregular menstrual cyclesEstimate prevalence odds ratiosCoronary artery diseaseOvulatory disordersHeart attackHigh cholesterolPolycystic ovary syndrome statusIrregular cyclesLower body mass indexCross-sectional studyAge of consentBody mass indexLogistic regression modelsMenstrual cyclePhysical activityLifestyle factorsArtery diseaseEffect modification